Clinical trial
Noninvasive Stage Identification of Hepatic Fibrosis Using 4D-MRI
NCT05385237 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Stage Identification of Hepatic Fibrosis Using 4D-MRI
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2021
- Completion date
- December 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.